MME and polyneuropathy: Loss–of-function and missense mutations in the neprilysin gene are associated with polyneuropathy, and also with decreased tissue availability of neprilysin and reduced neprilysin enzymatic activity (61–63), although the relevance of the polyneuropathy to bradykinin is unknown.